click below
click below
Normal Size Small Size show me how
Women's Health
Menopause, Oral Contraceptives, Osteoperosis
| Question | Answer |
|---|---|
| Oral hormone replacement therapy | Premarin, Estradiol, Estrace, Gynodiol, Estropipate, Ortho-Est, Ogen, Estratab, Menest |
| Estradiol Transdermal Formulations | Estraderm, Alora, Climara, Esclim, Vivelle, Vivelle--Dot |
| Injectable estrogens | delestrogen |
| Vaginal estrogen formulations | estrace vaginal cream, ogen vaginal cream, premarin vaginal cream, vagifem vaginal tablet |
| Combination estrogen-progestin products | activella, femhrt, prempro, premphase, climara pro, combipatch |
| combination estrogen-androgen products | estratest HS, synthest HS, estratest, syntest DS |
| estrogen side effects | breast tenderness, heavy bleeding, headache, nausea |
| progestin side effects | depression, HA, irritability |
| estrogen + progestin | combined oral contraceptives (COC) |
| protestin-only (minipill) | appropriate for breast feeding women; efficacy is less than COC; free of CV risks |
| estrogens examples | ethinyl estradiol, mestranol |
| progestin examples | desogestrel, norgestrel, levonorgestrel, ethynodiol diacetate, norethindrone, norethynodrel |
| estrogen MOA | suppresses FSH, does not block ovulation |
| progestin MOA | blocks ovulation; creates impermeable cervical mucus; contributes to atrophy of endometrium |
| drugs that decrease OC | ampicillin, griseofulvin, sulfonamides, tetracycline, anticonvulsants, NNRTI's, PI's, pioglitazone, phenytoin, rifampin, theophylline |
| drugs that increase OC | atorvastatin, vit C, 3A4 inhibitors |
| OC decreases these drugs | anticoags, BZDs, hypoglycemics, methyldopa, phenytoin |
| OC increases these drugs | TCAs, BZDs, Beta blockers, theophylline |
| OC will increase the toxicity of this drug | cortisone |
| progestin only OC | Ortho micronor, Errin, Nor-QD, Nora-BE, Camila, Ovrette |
| monophasic low-dose estrogen OC | Alesse, Aviane, Lessina, Levlite, Loestrin, Microgestin FE, Yasmin, Levlen, Levora, Nordette, Portia, Seasonale, Cryselle, Lo/Ovral, Low-Ogestrel, Apri, Desogen, Ortho-cept, Ovcon-35, Brevicon, Necon, Nortrel, Ortho-Novum, Norinyl, Kariva, Mircette |
| Monophasic-high dose estrogen OC | ovral, ogestrel, demulen, Zovia, ovcon-50, necon, norinul, ortho-novum |
| Biphasic oral contraceptives | ortho-novum, necon |
| triphasic oral contraceptives | enpresse, tri-levlen, triphasil, trivora, tri-norinyl, necon, ortho-novum, cyclessa, otho-tricyclen lo, ortho-tricyclen, estrostep |
| transdermal OC | ortho evra |
| vaginal ring OC | nuva ring |
| contraceptive injection | depo-provera, lunelle |
| intrauterine contraceptive systems | progestasert, mirena |
| CI for COC use | breast cancer, DVT, PE, CVA or CAD, IHD, diabetes with nephropathy, neuropathy, retinopathy, headaches, hypertension (160/100), lactation (<6 weeks postpartum), liver disease, pregnancy, surgery with prolonged immobilization, structural heart disease |
| estrogen excess side effects | breast tenderness, fullness, cervical mucorrhea, edema, hypertension, melasma, migraine, nausea, bloating |
| progestin excess side effect | acne or oily scalp, breast regression, deprssion, hypomenorrhea, increased appetite, monilial vaginitis, tiredness, fatigue, weight gain |
| estrogen deficiency side effects | breakthrough bleeding, hypomenorrhea, spotting |
| progestin deficiency | amenorrhea, breakthrough bleeding, hypermenorrhea |
| drugs that increase the risk of osteoperosis | anticonvulsants, cytotoxic drugs, glucocorticoids, immunosuppressants, lithium, long term heparin use, progesterone, supraphysiological thyroxine doses, tamoxifen |
| initiation of therapy begins with these T scores | T score < -2.5 with no risk factors; T score < -1.5 with risk factors |
| Calcium Carb/Vit D | 1000-1500 mg/day for calcium; 400-800 U/day for vitamin D; caltrate 600 + D, calcilyte + Vitamin D, Oscal + Vit D |
| calcium carbonate | caltrate 600, tums, titralac, viactiv chews, mylanta lozenges |
| calcium citrate | citracal |
| Treatment for osteopersosis | Calcium + Vit D, Bisphosphonates, estrogen replacement therapy, selective estrogen receptor modulator, calcitonin, teriparatide |
| Bisphosphonates | Alendronate (Fosamax); Ibandronate (Boniva); Risedronate (Actonel); for treatment and prevention of osteoperosis |
| Alendronate dose | Prevention: 5 mg QD or 35 mg QW; Treatment: 10 mg QD or 70 mg QW |
| Ibandronate dose | 150 mg QM for prevention and treatment |
| Risedronate dose | Prevention: 5 mg QD; Treatment: 5 mg QD or 30 mg QW |
| Patient counseling on Bisphosphonates | take with full glass of water 30 minutes prior to first meal of day; stand upright for 30 minutes |
| DDIs of Bisphosphonates | calcium supplements (separate by 1 hour); Ranitidine, ASA increases GI side effects |
| Raloxifene ADRs | hot flashes, chest pain, syncope, nausea, diarrhea, vomiting, arthralgia, myalgia, insomnia, neuralgia, rash, sweating |
| Raloxifene DDI's | cholestyramine, ampicillin, warfarin |